Yuno Miyuki, Nagata Shoko, Fujita Toshitsugu, Fujii Hodaka
Chromatin Biochemistry Research Group, Combined Program on Microbiology and Immunology, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan.
Department of Biochemistry and Genome Biology, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki, Aomori 036-8562, Japan.
Biol Methods Protoc. 2021 Jul 9;6(1):bpab013. doi: 10.1093/biomethods/bpab013. eCollection 2021.
Engineered DNA-binding molecule-mediated chromatin immunoprecipitation (enChIP) is a technology for purifying specific genomic regions to facilitate identification of their associated molecules, including proteins, RNAs, and other genomic regions. In enChIP, the target genomic region is tagged with engineered DNA-binding molecules, for example, a variant of the clustered regularly interspaced short palindromic repeats (CRISPR) system consisting of a guide RNA (gRNA) and a catalytically inactive form of Cas9 (dCas9). In this study, to increase the flexibility of enChIP and expand the range of target cells, we generated murine stem cell virus (MSCV)-based retroviral plasmids for expressing dCas9. We constructed MSCV-based retroviral plasmids expressing dCas9 fused to a 3xFLAG-tag (3xFLAG-Sp-dCas9) and various drug resistance genes. We showed that by using these plasmids, it is feasible to purify target genomic regions with yields comparable to those reported using other systems. These systems might give enChIP users greater flexibility in choosing optimal systems for drug selection of transduced cells.
工程化DNA结合分子介导的染色质免疫沉淀(enChIP)是一种用于纯化特定基因组区域以促进鉴定其相关分子(包括蛋白质、RNA和其他基因组区域)的技术。在enChIP中,目标基因组区域用工程化DNA结合分子进行标记,例如,由引导RNA(gRNA)和催化失活形式的Cas9(dCas9)组成的成簇规律间隔短回文重复序列(CRISPR)系统的变体。在本研究中,为了提高enChIP的灵活性并扩大靶细胞范围,我们构建了基于小鼠干细胞病毒(MSCV)的用于表达dCas9的逆转录病毒质粒。我们构建了基于MSCV的表达与3xFLAG标签融合的dCas9(3xFLAG-Sp-dCas9)和各种耐药基因的逆转录病毒质粒。我们表明,通过使用这些质粒,纯化目标基因组区域是可行的,其产量与使用其他系统报道的产量相当。这些系统可能会让enChIP用户在选择用于转导细胞药物筛选的最佳系统方面有更大的灵活性。